Latest filings (excl ownership)
6-K
Medicure Receives Us Fda Fast Track Designation for MC-1 for Pnpo Deficiency
26 Apr 24
20-F
2023 FY
Annual report (foreign)
8 Apr 24
6-K
Current report (foreign)
8 Apr 24
6-K
Current report (foreign)
4 Apr 24
6-K
Current report (foreign)
5 Dec 23
6-K
Medicure Announces Fda Provides Complete Approval to Enroll Patients In Its Pivotal Phase 3 Trial for Treatment of Rare Pediatric Disease
24 Nov 23
6-K
Current report (foreign)
21 Nov 23
6-K
Current report (foreign)
5 Sep 23
6-K
Current report (foreign)
24 Jul 23
6-K
Current report (foreign)
31 May 23
20-F
2022 FY
Annual report (foreign)
6 Apr 23
6-K
Medicure Announces Resignation of Board Member and Grant of Stock Options
1 Feb 23
6-K
Current report (foreign)
25 Nov 22
6-K
Condensed Consolidated Interim Financial Statements
23 Nov 22
6-K
Current report (foreign)
17 Nov 22
6-K
Current report (foreign)
5 Oct 22
6-K
Current report (foreign)
24 Aug 22
6-K
Current report (foreign)
24 Aug 22
6-K
Current report (foreign)
17 Aug 22
6-K
Medicure Announces Results of 2022 Agm
21 Jun 22
6-K
Current report (foreign)
31 May 22
6-K
Current report (foreign)
31 May 22
20-F
2021 FY
Annual report (foreign)
28 Apr 22
6-K
Current report (foreign)
27 Apr 22
6-K
Current report (foreign)
27 Apr 22
6-K
Current report (foreign)
26 Apr 22
6-K
Medicure Announces Resignation of Chief Financial Officer and Succession Plan
23 Mar 22
6-K
Medicure's Subsidiary - Marley Drug to Partner with RxSpark, the Next Generation in Pharmacy Discount Programs, to be its Sole Mail-Order Pharmacy
25 Feb 22
6-K
Medicure Launches E-Commerce Pharmacy Platform - www.marleydrug.com Through its Subsidiary Marley Drug Pharmacy
9 Feb 22
6-K
Current report (foreign)
23 Nov 21
6-K
Medicure Plans To Launch Innovative E-Commerce Pharmacy Platform Offering Hundreds of Medications Directly To Millions of Americans
23 Nov 21
6-K
Current report (foreign)
23 Nov 21
6-K
Current report (foreign)
5 Nov 21
6-K
Current report (foreign)
27 Aug 21
6-K
Current report (foreign)
27 Aug 21
6-K
Medicure Announces Grant of Stock Options
30 Jul 21
6-K
Medicure Announces Appointment of David Gurvey as Chief Financial Officer
24 Jun 21
6-K
Current report (foreign)
2 Jun 21
6-K
Current report (foreign)
11 May 21
6-K
Current report (foreign)
11 May 21
Latest ownership filings